Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Myelodysplastic Syndromes 1Mesothelioma, Malignant 1Leukemia 1Congenital Abnormalities 1

Interventions

Polymerase Chain Reaction 2Immunoenzyme Techniques 2Flow Cytometry 2sargramostim 1motexafin gadolinium 1incomplete Freund's adjuvant 1Watchful Waiting 1Microarray Analysis 1Ipilimumab 1Gene Expression Profiling 1Fentanyl 1Doxorubicin 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Congenital Abnormalities × incomplete Freund's adjuvant × Thoracic × Clear all
NCT00398138 2016-03-02

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
22 enrolled 7 charts
MyeloidOther hematologic neoplasmOther solid neoplasmThoracic

Congenital Abnormalities, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Leukemia, Lung Neoplasms, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡